| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |